
Novartis AG - Company Profile and SWOT Analysis
Description
Novartis AG - Company Profile and SWOT Analysis
Summary
Novartis AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Novartis AG (Novartis) is engaged in research, development, manufacturing, distribution, marketing, and sale of innovative medicines. It provides a diverse range of products across various therapeutic areas, including cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology. Novartis distributes its products to a wide array of stakeholders, including pharmacists, private health systems, government agencies, physicians, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems, under brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, on a global scale. It operates manufacturing facilities in the US, Switzerland, Austria, Slovenia, China, France, and Italy. Novartis is headquartered in Basel, Switzerland.
Scope
Summary
Novartis AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Novartis AG (Novartis) is engaged in research, development, manufacturing, distribution, marketing, and sale of innovative medicines. It provides a diverse range of products across various therapeutic areas, including cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology. Novartis distributes its products to a wide array of stakeholders, including pharmacists, private health systems, government agencies, physicians, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems, under brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, on a global scale. It operates manufacturing facilities in the US, Switzerland, Austria, Slovenia, China, France, and Italy. Novartis is headquartered in Basel, Switzerland.
Scope
- Detailed information on Novartis AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis
- An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments
- Intelligence on Novartis AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novartis AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Novartis AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novartis AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Novartis AG's business structure, strategy and prospects.
Table of Contents
51 Pages
- Company Snapshot
- Novartis AG: Company Overview
- Novartis AG: Overview and Key Facts
- Novartis AG: Overview
- Novartis AG: Key Facts
- Novartis AG: Key Employees
- Novartis AG: Key Employee Biographies
- Novartis AG: Major Products and Services
- Novartis AG: Management Statement
- Novartis AG: Locations and Subsidiaries
- Novartis AG: Key Competitors
- Novartis AG: Company Analysis
- Novartis AG: Business Description
- Novartis AG: SWOT Analysis
- Novartis AG: SWOT Overview
- Novartis AG: Strengths
- Novartis AG: Weaknesses
- Novartis AG: Opportunities
- Novartis AG: Threats
- Novartis AG: Corporate Financial Deals Activity
- Novartis AG: Financial Deals Overview
- Novartis AG: Targets and Partners
- Novartis AG: Top Deals 2021 - 2025YTD*
- Novartis AG: Advisors
- Novartis AG: Top Legal Advisors
- Novartis AG: Top Financial Advisors
- Novartis AG: Mergers and Acquisitions
- Novartis AG: Corporate Venturing
- Novartis AG: Partnership
- Novartis AG: Divestments
- Novartis AG: Recent Developments
- Novartis AG: News and Events Summary
- Novartis AG: Business Expansion
- Novartis AG: Corporate Governance
- Novartis AG: Financial Performance
- Novartis AG: Market Developments
- Novartis AG: Research & Development
- Novartis AG: Strategy and Operations
- Appendix
- Contact Us
- Methodology
- About MarketLine
- List of Tables
- Table 1: Novartis AG: Key Facts
- Table 2: Novartis AG: Key Employees
- Table 3: Novartis AG: Locations and Subsidiaries
- Table 4: Novartis AG: Key Competitors
- Table 5: Novartis AG: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: Novartis AG: M&A Activity by Geography (TTM*)
- Table 7: Novartis AG: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
- Table 8: Novartis AG: M&A Average Deal Size - Value (US$m)
- Table 9: Novartis AG: Targets and Partners
- Table 10: Novartis AG: Top Deals 2021 - 2025YTD*
- Table 11: Novartis AG: Legal Advisor Ranking by Value (US$m)
- Table 12: Novartis AG: Financial Advisor Ranking by Value (US$m)
- Table 13: Novartis AG: M&A Volume and Value Trend (2021 - YTD*2025)
- Table 14: Novartis AG: M&A Activity by Geography (2021 - YTD*2025)
- Table 15: Novartis AG: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
- Table 16: Novartis AG: Corporate Venturing by Geography (2021 - YTD*2025)
- Table 17: Novartis AG: Partnership Volume and Value Trend (2021 - YTD*2025)
- Table 18: Novartis AG: Partnership Trend by Deal Type (2021 - YTD*2025)
- Table 19: Novartis AG: Divestments Volume and Value Trend (2021 - YTD*2025)
- Table 20: Novartis AG: Divestments by Geography (2021 - YTD*2025)
- Table 21: Novartis AG: News and Events Summary
- Table 22: Novartis AG: Business Expansion
- Table 23: Novartis AG: Corporate Governance
- Table 24: Novartis AG: Financial Performance
- Table 25: Novartis AG: Market Developments
- Table 26: Novartis AG: Research & Development
- Table 27: Novartis AG: Strategy and Operations
- List of Figures
- Figure 1: Novartis AG: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Novartis AG: M&A Activity by Geography (TTM*)
- Figure 3: Novartis AG: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
- Figure 4: Novartis AG: M&A Average Deal Size - Value (US$m)
- Figure 5: Novartis AG: M&A Volume and Value Trend (2021 - YTD*2025)
- Figure 6: Novartis AG: M&A Activity by Geography (2021 - YTD*2025)
- Figure 7: Novartis AG: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
- Figure 8: Novartis AG: Corporate Venturing by Geography (2021 - YTD*2025)
- Figure 9: Novartis AG: Partnership Volume and Value Trend (2021 - YTD*2025)
- Figure 10: Novartis AG: Partnership Trend by Deal Type (2021 - YTD*2025)
- Figure 11: Novartis AG: Divestments Volume and Value Trend (2021 - YTD*2025)
- Figure 12: Novartis AG: Divestments by Geography (2021 - YTD*2025)
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.